Cargando…

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases

The inhibitory regulators, known as immune checkpoints, prevent overreaction of the immune system, avoid normal tissue damage, and maintain immune homeostasis during the antimicrobial or antiviral immune response. Unfortunately, cancer cells can mimic the ligands of immune checkpoints to evade immun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Xin, Zhan, Huajie, Ye, Yuguang, Yang, Jinjin, Zhang, Minghui, Li, Jing, Zhuang, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670224/ https://www.ncbi.nlm.nih.gov/pubmed/34917131 http://dx.doi.org/10.3389/fgene.2021.785153

Ejemplares similares

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer
por: Seesaha, Poshita-Kumari, et al.
Publicado: (2021)

A Gene Panel for Early Identification of Future Responders to Immune Checkpoint Blockade
por: Panda, Anshuman, et al.
Publicado: (2022)

A current and future perspective on T cell receptor repertoire profiling
por: Shen, Yiran, et al.
Publicado: (2023)

CRISPR/Cas Genome Editing in Potato: Current Status and Future Perspectives
por: Tiwari, Jagesh Kumar, et al.
Publicado: (2022)

Rare blood group registry in India-current challenges and future perspectives
por: Datta, Suvro Sankha, et al.
Publicado: (2023)

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives
por: Liu, Zherui, et al.
Publicado: (2023)

Livestock phenomics and genetic evaluation approaches in Africa: current state and future perspectives
por: Houaga, Isidore, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors in the Treatment of Renal Cancer: Current State and Future Perspective
por: Lavacchi, Daniele, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives
por: Rebuzzi, Sara Elena, et al.
Publicado: (2022)

Two-Way Development of the Genetic Model for Endometrial Tumorigenesis in Mice: Current and Future Perspectives
por: Maru, Yoshiaki, et al.
Publicado: (2021)

Role of cytokinins in seed development in pulses and oilseed crops: Current status and future perspective
por: Sharma, Sandhya, et al.
Publicado: (2022)

Editorial: 10 years of Frontiers in genetics: past discoveries, current challenges and future perspectives
por: Cho, William C., et al.
Publicado: (2023)

Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma
por: Apostolidis, John, et al.
Publicado: (2020)

Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma
por: Hotta, Katsuyuki, et al.
Publicado: (2020)

Immune Checkpoint Inhibition for Triple-Negative Breast Cancer: Current Landscape and Future Perspectives
por: Yi, Huimei, et al.
Publicado: (2021)

MCM10 is a Prognostic Biomarker and Correlated With Immune Checkpoints in Ovarian Cancer
por: Wu, Zhenzhen, et al.
Publicado: (2022)

Developing Successful Breeding Programs for New Zealand Aquaculture: A Perspective on Progress and Future Genomic Opportunities
por: Symonds, Jane E., et al.
Publicado: (2019)

Current Progress in Evolutionary Comparative Genomics of Great Apes
por: Yousaf, Aisha, et al.
Publicado: (2021)

SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma
por: Zhou, Quanwei, et al.
Publicado: (2022)

The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma
por: Yu, Xiaozhou, et al.
Publicado: (2021)

Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma
por: Cong, Tianhao, et al.
Publicado: (2022)

Genomics in Egypt: Current Status and Future Aspects
por: El-Attar, Eman Ahmed, et al.
Publicado: (2022)

EFNA3 Is a Prognostic Biomarker Correlated With Immune Cell Infiltration and Immune Checkpoints in Gastric Cancer
por: Zheng, Peng, et al.
Publicado: (2022)

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma
por: Hu, Xinyao, et al.
Publicado: (2022)

Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives
por: Zhang, Zhening, et al.
Publicado: (2020)

Landscape of Immunotherapy Options for Colorectal Cancer: Current Knowledge and Future Perspectives beyond Immune Checkpoint Blockade
por: Gorzo, Alecsandra, et al.
Publicado: (2022)

Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives
por: Yang, Changjiang, et al.
Publicado: (2023)

Perspectives on the Role of Histone Modification in Breast Cancer Progression and the Advanced Technological Tools to Study Epigenetic Determinants of Metastasis
por: Zhuang, Jialang, et al.
Publicado: (2020)

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma
por: Hu, Xinyao, et al.
Publicado: (2023)

ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
por: Yi, Ruibin, et al.
Publicado: (2020)

Corrigendum: Developing an immune-related signature for predicting survival rate and the response to immune checkpoint inhibitors in patients with glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

T-Cell Prolymphocytic Leukemia: An Overview of Current and Future Approaches
por: Colon Ramos, Ana, et al.
Publicado: (2021)

Dissecting the Role of Immune Checkpoint Regulation Patterns in Tumor Microenvironment and Prognosis of Gastric Cancer
por: Zhen, Zili, et al.
Publicado: (2022)

Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules
por: Alotaibi, Faizah
Publicado: (2023)

Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies
por: Yang, Wenwen, et al.
Publicado: (2021)

Drosophila comet assay: insights, uses, and future perspectives
por: Gaivão, Isabel, et al.
Publicado: (2014)

Recent advances in epigenetic anticancer therapeutics and future perspectives
por: Ren, Liwen, et al.
Publicado: (2023)

Clinical and genetic analysis VSX1 variants among families with keratoconus in northwest China
por: Zhang, Jinjin, et al.
Publicado: (2023)

Genetics of Recurrent Miscarriage: Challenges, Current Knowledge, Future Directions
por: Rull, Kristiina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_90g85i9ri5h24j7oteniaojih6